MQ calls on next UK Government to support mental health research
Australia's Doctor's Guidelines for Treatment of Schizophrenia - Latest Version
Intra-Cellular Therapies to Present Data on its Novel Compound ITI-333
Cognitive and functional deficits in people with schizophrenia: Evidence for accelerated or exaggerated aging?
Polypharmacy in Schizophrenia May Have Adverse Effect on Cognition
Add-on Antidepressants in the Naturalistic Treatment of Schizophrenia Spectrum Disorder - When, Who, and How?
Minerva Provides Update on Phase 3 Design and Development Strategy for MIN-101
Interpersonal sensitivity in those at clinical high risk for psychosis mediates the association between childhood bullying victimisation and paranoid ideation: A virtual reality study
Harvey Rosenthal: The “Worried Well” – A False Narrative Meant To Divide
Minerva Neurosciences stock rises 7% on plans to advance schizophrenia drug to late-stage trials
Blood Test Might Someday Distinguish (between) Early Depression, Schizophrenia
Neurocognitive deficits in schizophrenia. Are we making mountains out of molehills?
New thinking on out-of-date thinking on schizophrenia
Severe mental illness linked to much higher risk for cardiovascular disease
Study recruiting on curcumin and negative symptoms of sz
The Boys Who Grew Breasts: Portraits of the Effects of Risperdal
Vitamin D Deficiency May Worsen Cognitive Impairments in Psychotic Disorder
Antipsychotic Symptoms Persist for Patients Seeking Treatment
Schizophrenia Linked to Pregnancy Complications, Study Suggests Rates of preterm births, C-sections and ICU treatment higher for mothers with the mental illness
Characteristics and Service Use of Older Adults with Schizoaffective Disorder Versus Older Adults with Schizophrenia and Bipolar Disorder
ECT is Safe and Nothing to Fear
Google offshoot Verily loses top scientist (Tom Insel) leading its mental health project
Schizophrenia: From childhood to genomes
Schizophrenia subtype diagnosis and potential new treatment avenues
About a third of FDA-approved drugs go on to have major safety issues
Use of Omega-3 Polyunsaturated Fatty Acids as Augmentation Therapy in Treatment-Resistant Schizophrenia
Review supports long-term effects of antipsychotics for schizophrenia
Characterizing Awareness of Schizophrenia Among Facebook Users by Leveraging Facebook Advertisement Estimates
Low Cost Medications on the Dark Web - Anyone Tried this?
← previous page
next page →